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This paper presents a theory and an experimental validationfor design and analysis of digital PCR devices that rely on
multiple sets of wells, each set of a different volume. We also
present design principles to develop user-specified devices. This
approach, defined here as “multivolume digital PCR” (MV digital
PCR), enables quantification of nucleic acid with wide dynamic
range and high resolution while using a minimal number of wells.
The development of simple stand-alone devices for quantitative
nucleic acid diagnostics would further enable diagnosis and treat-
ment in point-of-care settings. Precise, absolute quantification of
nucleic acid levels, especially at low levels of detection, would have
particular impact in applications such as viral load analysis (e.g.,HIV,
hepatitis, cytomegalovirus (CMV), enterovirus),112 bacterial de-
tection, and quantification in food or water sources without
culturing,1315 multiplexed diagnostics, and minimal residual
disease.16,17 Real time PCR is often considered the gold standard
for nucleic acid quantification1820 but has limited utility in the field
because it requires data collection and analysis over the entire course
of the reaction, careful control of conditions, and internal calibration
standards and typically gives relative levels rather than absolute
concentrations.9,2123 Digital PCR2341 provides a way to obtain
absolute nucleic acid levels directly using only end point analysis
with high resolution and sensitivity.
Typical digital PCR platforms2532 use wells of only a single
volume and, therefore, require a large number of wells to achieve a
large dynamic range. In single-volume digital PCR, the upper limit
of quantification (ULQ) is determined predominantly by the
volume of individual wells; the number of wells also contributes to
the upper limit. The lower detection limit (LDL) is determined by
the total volume; thus, a large dynamic range requires tens of
thousands to millions of small wells. While acceptable in standard
laboratory settings, this is a potential limitation for point-of-care
purposes, which would benefit from fewer wells to make chip
design and readout more manageable and minimize device
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ABSTRACT: This paper presents a protocol using theoretical methods and free
software to design and analyze multivolume digital PCR (MV digital PCR) devices;
the theory and software are also applicable to design and analysis of dilution series in
digital PCR. MV digital PCR minimizes the total number of wells required for
“digital” (single molecule) measurements while maintaining high dynamic range
and high resolution. In some examples, multivolume designs with fewer than 200
total wells are predicted to provide dynamic range with 5-fold resolution similar to
that of single-volume designs requiring 12 000 wells. Mathematical techniques were utilized and expanded to maximize the
information obtained from each experiment and to quantify performance of devices and were experimentally validated using the
SlipChip platform. MV digital PCR was demonstrated to perform reliably, and results from wells of different volumes agreed with
one another. No artifacts due to different surface-to-volume ratios were observed, and single molecule amplification in volumes
ranging from 1 to 125 nL was self-consistent. The device presented here was designed to meet the testing requirements for
measuring clinically relevant levels of HIV viral load at the point-of-care (in plasma, <500 molecules/mL to >1 000 000 molecules/
mL), and the predicted resolution and dynamic range was experimentally validated using a control sequence of DNA. This approach
simplifies digital PCR experiments, saves space, and thus enables multiplexing using separate areas for each sample on one chip, and
facilitates the development of new high-performance diagnostic tools for resource-limited applications. The theory and software
presented here are general and are applicable to designing and analyzing other digital analytical platforms including digital
immunoassays and digital bacterial analysis. It is not limited to SlipChip and could also be useful for the design of systems on
platforms including valve-based and droplet-based platforms. In a separate publication by Shen et al. (J. Am. Chem. Soc., 2011, DOI:
10.1021/ja2060116), this approach is used to design and test digital RT-PCR devices for quantifying RNA.
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footprint. In addition, in single volume approaches, resolution and
dynamic range cannot be adjusted independently, regardless of the
actual requirements of a given application, leading to inefficient
experimental design.
Serial dilutions have been used in digital PCR systems2329,3133
to expand the dynamic range, but this approach only expands the
dynamic range to higher concentrations and does not increase
sensitivity. Most digital PCR systems use wells with small (few nL
or pL) volumes, making quantification of low concentrations
(∼100 molecules/mL) difficult. Digital PCR in wells with larger
volumes combined with serial dilution can be used to quantify low
and high concentrations, but this approach would waste both space
and reagent. Using serial dilutions increases sample manipulation
and processing, adds complexity, and increases the potential for
cross-contamination, making it less applicable in point-of-
care settings.
MV digital PCR overcomes these limitations of serial dilutions
and allows the user to quantify nucleic acid while adjusting
dynamic range and resolution separately (Figure 1a). Wells of
different volumes decouple the link between the total volume of
all wells and the size and number of smallest wells: the smallest
wells enable quantification of high concentrations, while the wells
of large volumes enable high sensitivity by efficiently increasing
the total volume. MV digital PCR can achieve the same dynamic
range as single-volume digital PCR without the need for an
excessive number of wells (compare Figure 1b,c, or Figure S1a,b,
Supporting Information). By reducing the number of wells
required for a given dynamic range, more samples can be tested
on a single chip, allowing for multiplexed testing. TheMV system
also requires less reagent (>67% less for the design described in
this paper) than serial dilution, thus reducing cost.
A key feature of the approach in this paper is the mathematical
treatment for combining of results frommultiple volumes. While
the use of multiple volumes can be mathematically equiva-
lent to using serial dilutions, most work in this area has
treated each dilution separately.2329,33 Combining results
from wells of multiple volumes increases accuracy and can be
achieved using the maximum likelihood estimate (MLE) or
most probable number (MPN) theory,4249 as it is known in
culture-based bacterial quantification systems. Three repli-
cates (i.e., wells) at three dilutions has long been the standard
for this method, though it has been expanded to include
increased numbers of wells to improve quantification using
multivolume approaches.4749 Such a “three replicates at
three dilutions” approach has been used to perform “MPN-
PCR”-based quantification,1315 although current digital
PCR systems2532 have used only elements of MPN for
analysis31,32 of serial dilution experiments. Microfluidic
devices for multivolume digital PCR, and appropriate statis-
tical methods for proper analysis, have not been previously
developed.
Here, we wished to expand and test the MPN theory in the
context of multivolume digital PCR. We also wished to perform
experimental tests of this approach because it was not obvious
that digital PCR would function properly at all well volumes due
to the potential artifacts caused by different surface-to-volume
ratios and different effective concentrations of singlemolecules in
each volume. The SlipChip31,5056 is an attractive platform for
this multivolume approach, as it can easily incorporate wells of
different sizes. The simplicity of the device (e.g., lack of valves
and pumps and control channels) allowed for the design of
nonlinear (e.g., radial) arrays to further reduce the footprint of
the device. We chose to validate theMV digital PCR approach by
designing a SlipChip device that meets the detection require-
ments to monitor HIV viral load. An ideal diagnostic tool to
measure HIV viral load would have a wide dynamic range to
measure 500 to 1 000 000 molecules/mL in plasma while achiev-
ing a resolution of 3-fold changes (0.5 log) in viral load at a
confidence level of at least 95% with a power level of 95%.17
Here, we validated the design and the MV digital PCR
approach using a control DNA template; in a separate pub-
lication, we show that MV digital RT-PCR can also be
performed for RNA using the design and analysis techniques
provided here.55 To apply MV digital nucleic acid quantifica-
tion to point-of-care settings, digital isothermal amplification
methods5658 and visual readout methods will also be desired,
but MV digital PCR provides an excellent starting platform to
achieve this ultimate goal.
’EXPERIMENTAL SECTION
Materials, DNA template preparation, and MV digital PCR
experiments are described in the Experimental Section of the
Supporting Information.
Computer Programs. The suite of programs developed in this
work are provided in the Supporting Information (ac201658s_
si_002.zip) along with detailed descriptions. The software and any
future updates to it will be available at http://cheme.caltech.edu/
groups/rfi/. The user inputs the data into Datainput.xls and needs
to interact with MVdPCR_DataInput.m; MVdPCR_RunSim.m;
MVdPCR_Find_device_param.m; and MVdPCR_RunPlot.m pro-
grams. These programs would automatically execute additional pro-
grams provided in the suite:MVdPCR_MLE.m;MVdPCR_Simulate.
m; MVdPCR_Find_device_resol.m; MVdPCR_Find_device_lower.
m; MVdPCR_Find_approx1.m; and MVdPCR_Plot_points.m.
Figure 1. (a) General schematic of multivolume system used for digital
PCR (MV digital PCR), with relationship between device features and
performance abilities. Two hypothetical devices with identical dynamic
range and with equal spacing (300 μm) between wells; (b) a model MV
digital PCR system (160 wells each at 125, 25, 5, and 1 nL); and (c) a
single volume digital PCR system (12 000 wells at 2.08 nL). With these
design parameters, the footprint of the MV wells is approximately 7-fold
smaller than the single volume design. Zoom in to view. Note:Well sizes
are based on assumption of cubic dimensions, and in the MV design, the
vertical spacing was kept constant from center of well to center of well, as
would be required for proper slipping in a SlipChip platform and is based
on a 300 μm spacing between the largest wells.
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’RESULTS AND DISCUSSION
Poisson Analysis of Single-Volume PCR. There are two key
assumptions that need to be maintained in order for digital PCR
methods and analysis to accurately quantify nucleic acid con-
centrations: (1) having at least one target molecule in a well is
necessary and sufficient for a positive signal, and (2) target
molecules do not interact with one another or device surfaces, to
avoid biasing their distribution. At the simplest level of analysis,
when molecules are at low enough densities that there is either 0
or 1 molecule within a well, concentrations can be estimated
simply by counting positives. However, if the two key assump-
tions above hold true, then Poisson and binomial statistics can be
used to obtain quantitative results from experiments resulting in
one positive well to experiments resulting in one negative
well.59,60 The Poisson distribution (eq 1), in the context of
digital PCR, gives the probability, p, that there are k target
molecules in a given well based on an average concentration per
well, v 3 λ, where v is the well volume (mL) and λ is the bulk
concentration (molecules/mL). In digital PCR, the same readout
occurs for all k > 0, so if k = 0, then eq 1 simplifies to give the
probability, p, that a given well will not contain target molecules
(the well is “negative”).
p ¼ ððv 3 λÞk 3 eðv 3 λÞÞ=k!,
and for k ¼ 0ðempty wellÞ, p ¼ eðv 3 λÞ ð1Þ
In single-volume systems, the number of negative wells, b, out
of total wells, n, can serve as an estimate for p, so expected results
can be estimated from known concentrations, or observed results
can be used to calculate expected concentrations (eq 2).
b ¼ n 3 eðv 3 λÞ or λ ¼ lnðb=nÞ=v ð2Þ
The binomial equation is used to determine the probability, P,
that a specific experimental result (with a specific number of
negatives, b, and positives, n b, out of the total number of wells,
n, at each volume) will be observed, on the basis of λ (eq 3),
where
n
b
 !
¼ n!b!ðn  bÞ!
P ¼ n
b
 !
3 p
b
3 ð1 pÞnb or
P ¼ n
b
 !
3 ðev 3 λÞb 3 ð1 ev 3 λÞnb ð3Þ
Analysis of Multivolume Systems. Incomplete analysis of
multivolume systems could be performed by simply selecting a
single volume and analyzing it as described above; this is the
approach that has typically been taken in serial dilution systems.
The single volume that minimizes the standard error is generally
chosen; this typically occurs when 1040% of wells are nega-
tive.33,42,43 However, this method wastes the information from
the other “dilutions” (or volumes) and would require using
different dilutions for different sample concentrations. Combin-
ing the results from wells of different volumes fully minimizes the
standard error and provides high-quality analysis across a very
large dynamic range. This is achieved by properly combining the
results of multiple binomial distributions (one for each volume);
specifically, the probability of a specific experimental result P
(defined above) is the product of the binomials for each volume
(eq 4),4245 where P is defined as a function of the bulk
concentration λ, P = f(λ),
f ðλÞ ¼ P ¼ Y ni
bi
 !
3 ðevi 3 λÞbi 3 ð1 evi 3 λÞnibi ð4Þ
For a given set of results, the MPN is found by solving for the
value of λ that maximizes P. In general, taking the derivative of an
equation and solving for zero provides the maximum and/or
minimum values of that equation; as a binomial distribution (and
subsequently the product of binomials) has only a single max-
imum, solving the derivative of eq 4 for zero provides the “most
probable” concentration. The standard deviation, σ, is more
appropriately applied to ln (λ) than to λ, because the distribution
of P based on ln (λ) is more symmetrical than that for λ.42,43 In
addition, this approach provides better accuracy for low con-
centrations by enforcing the constraint that concentrations must
be positive. Thus, a change of variables is needed during the
derivations so σ can be found for ln (λ). Therefore, f(λ) (eq 4) is
converted to F(Λ) (eq 5), where θ = ev and Λ = ln(λ).
FðΛÞ ¼ P ¼ Y ni
bi
 !
3 ðθe
Λ
i Þbi 3 ð1 θe
Λ
i Þnibi ð5Þ
The derivative is easier to handle if the natural log is applied to
eq 5, as the individual components are separated, but the overall
result is unchanged (eq 6).43
LðΛÞ ¼ ln FðΛÞ ¼ ∑
m
i¼ 1
ln
ni
bi
0
@
1
A þ bi 3 eΛ 3 lnðθiÞ
0
@
þ ðni  biÞ 3 lnð1 θe
Λ
i Þ

ð6Þ
The first derivative is then
∂LðΛÞ
∂Λ
¼ ∑
m
i¼ 1
0 þ bi 3 eΛ 3 lnðθiÞ 
ðni  biÞ 3 eΛ 3θe
Λ
i
ð1 θeΛi Þ 3
lnðθiÞ
 !
ln(θi) can be replaced with vi:
¼ eΛ 3 ∑
m
i¼ 1
bi 3 vi þ
ðni  biÞ 3 vi 3 θe
Λ
i
ð1 θeΛi Þ
 !
substituting (ni ti) for bi (where ti is the number of positive
wells)
¼ eΛ 3 ∑
m
i¼ 1
ni 3 vi þ ti 3 vi þ
ti 3 vi 3θ
eΛ
i
ð1 θeΛi Þ
 !
rearranging to put all ti’s over the denominator
¼ eΛ 3 ∑
m
i¼ 1
ni 3 vi þ
ti 3 vi
ð1 θeΛi Þ
 ti 3 vi 3θ
eΛ
i
ð1 θeΛi Þ
þ ti 3 vi 3θ
eΛ
i
ð1 θeΛi Þ
 !
8161 dx.doi.org/10.1021/ac201658s |Anal. Chem. 2011, 83, 8158–8168
Analytical Chemistry ARTICLE
and simplifying and rearranging in terms of bi
∂LðΛÞ
∂Λ
¼ eΛ 3 ∑
m
i¼ 1
ni 3 vi þ
ðni  biÞ 3 vi
ð1 θeΛi Þ
 !
ð7Þ
Setting eq 7 equal to 0, resubstituting λ, and rearranging then
gives eq 8. By solving eq 8 for λ, the expected concentration can
be determined from the number of empty wells. This can be done
using any solver function, and the accompanying code
MVdPCR_MLE.m (see Experimental Section) performs this
step using a globalized Newton method.
∑
m
i¼ 1
ni 3 vi ¼ ∑
m
i¼ 1
ðni  biÞ 3 vi
ð1 evi 3 λÞ ð8Þ
The standard error, σ, for a result can be found using the Fisher
information, I(X), for ln(λ),44 requiring the change of variable to
Λ. The Fisher information is defined in eq 9, where E[]
represents the expected value of the given variable.
1
variance
¼ 1
σ2
¼ IðΛÞ ¼ 
Z
∂
2LðΛÞ
∂Λ2
f ðx; θÞdx
¼ E  ∂
2LðΛÞ
∂Λ2
" #
ð9Þ
In eq 10, the second derivative of eq 6 is found.
∂
2LðΛÞ
∂Λ2
¼ eΛ 3 ∑
m
i¼1
ni 3 vi þ
ðni  biÞ 3 vi
ð1 θeΛi Þ
 !
þ eΛ 3 ∑
m
i¼ 1
eΛ 3 ðni  biÞ 3θe
Λ
i 3 vi 3 ðln θÞ
ð1 θeΛi Þ2
 !
¼ eΛ 3 ∑
m
i¼ 1
ni 3 vi 
ðni  biÞ 3 vi
ð1 θeΛi Þ
 !
 ðeΛÞ2 3 ∑
m
i¼ 1
ðni  biÞ 3 vi2 3 θe
Λ
i
ð1 θeΛi Þ2
 !
ð10Þ
Using this expression in eq 9 to then find the inverse variance
gives eq 11
1
σ2
¼ E eΛ 3 ∑
m
i¼ 1
ni 3 vi 
ðni  biÞ 3 vi
ð1 θeΛi Þ
 !"
 ðeΛÞ2 3 ∑
m
i¼ 1
ðni  biÞ 3 vi2 3θe
Λ
i
ð1 θeΛi Þ2
 !#
¼ eΛ 3 ∑
m
i¼ 1
ni 3 vi 
ðni  E½biÞ 3 vi
ð1 θeΛi Þ
 !
þ ðeΛÞ2 3 ∑
m
i¼ 1
ðni  E½biÞ 3 vi2 3 θe
Λ
i
ð1 θeΛi Þ2
 !
With E[bi] coming from eq 2
¼  eΛ 3 ∑
m
i¼ 1
ni 3 vi 
ðni  ni 3 θe
Λ
i Þ 3 vi
ð1 θeΛi Þ
 !
þ ðeΛÞ2 3 ∑
m
i¼ 1
ðni  ni 3θe
Λ
i Þ 3 vi2 3 θe
Λ
i
ð1 θeΛi Þ2
 !
¼  eΛ 3 ∑
m
i¼ 1
ni 3 vi  ni 3 vi 3
ð1 θeΛi Þ
ð1 θeΛi Þ
 !
þ ðeΛÞ2 3 ∑
m
i¼ 1
ni 3 ð1 θe
Λ
i Þ 3 vi2 3 θe
Λ
i
ð1 θeΛi Þ2
 !
¼ ðeΛÞ2 3 ∑
m
i¼ 1
ni 3 vi
2
3 θ
eΛ
i
ð1 θeΛi Þ
 !
¼ λ2 3 ∑
m
i¼ 1
ni 3 vi
2
3 e
vi 3 λ
ð1 evi 3 λÞ
 !
¼ λ2 3 ∑
m
i¼ 1
ni 3 vi
2
ðevi 3 λ  1Þ
 !
ð11Þ
This ultimately gives the standard error (eq 12), from which
confidence intervals can be generated (eq 13), where Z is the
upper critical value for the standard normal distribution,
σ ¼ 1ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
λ2 3∑
vi2 3 ni
eviλ  1
r ð12Þ
CI ¼ lnðλÞ ( Z 3 σ ð13Þ
One core design requirement of the device is to be able to
achieve a certain resolution (that is, distinguish a certain differ-
ence in concentration) at certain concentrations. As mentioned
above for HIV viral load monitoring, an ideal system would be
able to achieve 3-fold resolution for as low as 500 molecules/mL.
To be able to correctly resolve two different concentrations, the
risk of both false positives (Type I error) and false negatives
(Type II error) need to be taken into account.6,35,36,39,61 Samples
must give results at the desired confidence level (1-α, measure of
Type I error) and demonstrate this confidence level again and
again (Power: 1-β, measure of Type II error). When comparing
two results, the null hypothesis is that the results come from
samples that have statistically the same concentration. α is the
probability that two results that are determined to be statistically
different are in fact from the same sample, thus resulting in a false
positive. A 95% confidence level would correspond to α = 0.05
and an accepted false positive rate of 5%. The power level
measures the probability, β, that samples that are statistically
different at the desired confidence level give results that fall below
this confidence level. A 95% power level would correspond to
β = 0.05 and thus an accepted false negative rate of 5%. For the
analysis described in this paper, the 3-fold resolution is defined
such that samples with a 3-fold difference in concentration (e.g.,
500 and 1500molecules/mL)will give results that are statistically
different with at least 95% confidence (α< 0.05, less than 5% false
positives) at least 95% of the time (power level of 95%, β<0.05,
no more than 5% false negatives).
The Z-test (eq 14) was chosen to measure the confidence
level, where λ and σ are calculated using eqs 8 and 12,
respectively, for a set of two results (the specific number of
negatives, bi, out of the total number of wells, ni, at each volume i
of wells). The Z-test measures the probability that results are
statistically different, by assuming that the test statistics (left side
of eq 14) can be approximated by a standard normal distribution,
so Z corresponds to a known probability. The power level is
measured by simulating results from two different samples and
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determining the probability that they will give results that at least
meet the desired confidence level.
λ1  λ2ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
σ12 þ σ22
p ¼ Z, for 95% confidence λ1  λ2ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
σ12 þ σ22
p > 1:96
ð14Þ
For the Z-test, which assumes a normal distribution, to be
useful, it is important to verify that it can be used under a wide
range of conditions, including at low concentrations when there
are few positive wells or when the design consists of very few
wells. While in the limit of many wells the binomial distribution
can be approximated by a normal distribution, it is not obvious
that a normal approximation is appropriate for the test statistic
generated from the MPN-combined binomial distributions. To
validate the use of the Z-test under these conditions, the
confidence level measured from the Z-test was compared to
the confidence level measured on the basis of permutation tests.
The permutation test6264 is an exact method for determining
the confidence level based on the actual statistical distribution of
two results being compared. It was performed here by first
determining the concentration that would correspond to the
null hypothesis for the two sets of results. The null hypothesis
concentration was used to generate simulated sets of results
(10 000 simulations), and the confidence level was calculated on
the basis of where the original two results fell within the simula-
ted distribution. The results from the Z-test and permutation test
are in very good agreement for designs with 160 wells and even
for designs with much fewer wells (Table S1 (Supporting
Information) and as used in a forthcoming paper55).
Device Design. To meet the design requirements to monitor
HIV viral load, a multivolume device was designed with 160 wells
each at volumes of 125, 25, 5, and 1 nL (Table 1). A radial layout
of wells (Figure 2) provides an efficient use of space when
wells of significantly different volumes are used. In the initial
orientation of the radial multivolume SlipChip, the main wells
are aligned to create a continuous fluidic path that allows all of
the sample wells to be filled in one step using dead end
filling.52 The SlipChip can then be rotationally slipped (∼8)
to simultaneously isolate each well and overlap it with the
corresponding thermal expansion well (Figure 2). This device
has a LDL of 120 molecules/mL and a dynamic range where
at least 3-fold resolution is achieved from 520 to 3 980 000
molecules/mL (Table 1).
To validate both the statistical analysis and the performance of
the device, experiments were carried out to test the theoretical
predictions. Many experiments were required to obtain sufficient
statistics, and nine SlipChips were used for experiments. To
minimize variability among experiments, the etching depth of the
chips was closely monitored during the fabrication process. Due
to the variations in the printed masks and the actual etch depths
during fabrication, the actual volumes of the nominal 125, 25, 5,
and 1 nL wells were, on average, 127.47, 27.51, 5.03, and 1.12 nL,
respectively, with a coefficient of variation between chips of
0.20.5% for the average well size and 0.71.1% for individual
wells (see details in Supporting Information, Table S2). Due to
the small variation between chips, the average volumes were used
for analysis to calculate the sample concentrations.
Experimental Validation. A control 631 bp sequence of
DNA was used to validate the MV digital PCR approach.
A stock solution of DNA of well-defined sequence and length
was generated using PCR with subsequent purification (see
Experimental Section and sequence and primers in Supporting
Table 1. Summary of Device Design, Specifications, and Performance
number of
wells
volume per
well (nL)
total volume
(μL)
LDL
(molec./mL)a
LLQ-5
(molec./mL)b
LLQ-3
(molec./mL)b
ULQ
(molec./mL)c
160 125 20 150 250 680 31 800
160 25 4 760 1270 3390 159 000
160 5 0.8 3800 6350 16 950 795 000
160 1 0.16 18 900 31 750 84 700 3 977 000
overall device (wells of all volumes) 24.96 120 200 520 3 977 000
a LDL is the lower detection limit and is defined as the concentration which would have a 95% chance of generating a least one positive well and equals
the concentration calculated from three positive wells. b LLQ-5 and LLQ-3 refer to the lower limit of quantification for 5-fold and 3-fold resolution,
respectively. They correspond to the concentration calculated on the basis of 5 positive wells (for 5-fold resolution) or 13 positive wells (3-fold
resolution). cULQ is the upper limit of quantification and is defined as the concentration which would have a 95% chance of generating at least one
negative well and equals the concentration calculated on the basis of three negative wells. ULQ is reported as the upper of the two concentrations being
resolved. For this design, ULQ coincides for both 3- and 5-fold resolution.
Figure 2. Schematic for radial SlipChip to performMV digital PCR. Design consists of 160 wells each at 125, 25, 5, and 1 nL. Sample is loaded from the
center and after filling is rotationally slipped to isolate wells. After the reaction, wells containing template have enhanced signal and can be counted.
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Information). The initial concentration of this stock solution
was determined by UVvis, and the stock was then diluted to
levels required for testing of the chip. Concentrations were
tested across the entire dynamic range of the device: approxi-
mately 500, 1500, 8000, 20 000, 30 000, 100 000, 600 000, and
3 000 000 molecules/mL. A total of 80 experiments and 29
additional controls were performed, and the observed concen-
trations showed excellent agreement with the expected con-
centrations and demonstrated the accuracy of the device
performance over the entire dynamic range (Figure 3). The
experimental results consist of a “digital” pattern of positive and
negative wells. At a low input concentration of 1500 molecules/mL
(Figure 3a), the larger 125 and 25 nL wells provide the majority
of the information to determine the concentration. As expected,
at a higher concentration of 600 000 molecules/mL, positives
were found in the smaller 5 and 1 nL wells also (Figure 3b), and
these smaller wells provide the majority of the information used
to determine the concentration. Excellent agreement was found
between the input concentration and the measured concentra-
tion over 4 orders of magnitude (Figure 3c,d). These experi-
ments were performed over a period spanning over 4 months,
independently by two of the authors using multiple aliquots of
DNA.Of the 80 results, 65 fell within the 95%CI and 76 of the 80
results fell within the 99% CI. Experimental error (including
potential for DNA degradation over time and dilution and
pipetting errors) has likely made a contribution to the minor
broadening of the distribution of results beyond those statisti-
cally predicted, but we consider the overall agreement to be quite
Figure 3. Experimental results for MV digital PCR on SlipChip using control DNA. Representative false color images (yellow represents positive
wells that showed at least a 3-fold increase in intensity compared to negative wells) for solutions with input concentrations of (a) 1500 molecules/mL
and (b) 600 000 molecules/mL (zoomed in on smaller wells). (c, d) Graphical summary of all experiments comparing the input concentration, based
onUVvis measurements (black curve), and observed concentrations usingMV digital PCR (x and +) over the entire dynamic range. Represented as
(c) the actual concentration and (d) a ratio to better show distribution of results. Stock samples were approximately 500, 1500, 8000, 20 000, 30 000,
100 000, 600 000, and 3 000 000molecules/mL. The confidence intervals (CI) for the combined system (solid gray curves) indicate where 95% of the
experiments should fall. CI curves for the individual volumes (various dashed gray curves) are also provided to indicate over what range of
concentration each volume contributes.
Figure 4. Separate analysis of 10 experimental results for different well
volumes with an input concentration of 30 000molecules/mL shows the
distribution of measured concentrations for each volume and overall
agreement of results.
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good (Figure 3d). In this multivolume design, the 95% con-
fidence interval is narrow at a consistent level over a very large
range of concentrations: the CI is within 13.815% of the
expected value from 9500 to 680 000 molecules/mL and with-
in 13.817.5% from 5400 to 1 700 000 molecules/mL.
The experimental data tracked closely the theoretically pre-
dicted CI (Figure 3d).
As expected, the largest wells (125 nL) provided the largest
contribution to the overall confidence interval for samples in the
102104 molecules/mL range while the use of smaller and
smaller wells down to 1 nL in volume extended the dynamic
range with a 95% confidence interval above 106 molecules/mL
(Figure 3c,d). For each concentration, there was excellent
agreement among the individual results obtained from the wells
of different volumes, consistent with the accuracy of the overall
device. This agreement is illustrated for an input concentration of
30 000molecules/mL (Figure 4). At this concentration, the wells
of all volumes provided a reasonable number of positives and
negatives for quantification, and we found that the concentration
calculated from the results fell within the 95% confidence
intervals for individual volumes of wells (38 of 40 results), and
also, the averages from wells of each volumes were internally
consistent (Figure 4).
Having confirmed that the device performs accurately and
precisely, we tested whether the predicted levels of resolution
could be achieved. 3-Fold resolution was predicted to be
attained from a lower limit of quantification (LLQ-3) of 500
molecules/mL, so 20 sets of MV digital PCR experiments were
performed using pairs of samples at concentrations of 500 and
1500 molecules/mL. In these experiments, performed by the
same author, 19 out of 20 pairs of results fell within >95%
confidence range (Table S3, Supporting Information), consis-
tent with the expected power level. Pairing the experiments
reduces variability due to differences in sample degradation and
pipetting errors by different users. Upon randomization of all 20
pairs in Table S3 (Supporting Information) to produce 1000
pairs of results, the power level was still 92%, indicating that
while there is possibly some day-to-day and user-to-user
variability, it is not dominating the results. The maximum
expected resolution of this chip is about 1.5-fold, and this
resolution was tested with pairs of samples at concentrations of
20 000 and 30 000 molecules/mL by two of the authors. Here,
10 sets of experiments were performed, and all 10 pairs
showed >95% confidence (Table 2 and Supporting Informa-
tion, Table S4). For 1.5-fold resolution, even upon randomi-
zation of the original 10 pairs in Table 2 and Table S4
(Supporting Information) into 100 sets to produce 1000 pairs
of results, a 96.6% power level was maintained.
Protocol toDesignDevices andAccompanying Computer
Programs. We provided a protocol for designing devices that
combines simple empirical observationswith advanced and precise
software programs to efficiently design customized systems.Multi-
ple variables influence the overall performance characteristics of
MV digital PCR systems including: number of well sizes, number
of wells at each volume, and the “volumetric step” (VS, the
multiplication factor bywhich volumes are increased from smallest
to largest; VS = 5 was used in this paper). The first step in device
design is to identify the requirements for performance of the
device and any physical limitations on the design. Physical
limitations include limits on fabrication (volumes of smallest orTable 2. Experimental Results Testing 1.5-Fold Resolution
a
20 000 molec./mL 30 000 molec./mL
pair MPN σ MPN σ Z Z-test conf. (1-α)
1 18 528 0.076 28 995 0.078 4.120 0.9999
2 19 126 0.076 27 027 0.077 3.192 0.9980
3 17 354 0.076 25 954 0.077 3.717 0.9995
4 17 077 0.076 29 976 0.078 5.163 1.0000
5 15 183 0.077 30 357 0.078 6.330 1.0000
6 16 518 0.076 25 279 0.077 3.929 0.9999
7 17 948 0.076 38 315 0.079 6.898 1.0000
8 20 442 0.076 36 545 0.079 5.294 1.0000
9 18 013 0.076 33 205 0.079 5.592 1.0000
10 23 967 0.077 31 779 0.078 2.577 0.9900
avg. 18 226 0.076 30 316 0.078 4.672 1.0000
a 20 000 molecules/mL vs. 30 000 molecules/mL, 20 experiments total.
Table 3. Numbers of Total and Positive or Negative Wells Required by Theory to Achieve Specific Resolution Levels in Single-
Volume Systems (with Criteria of 95% Confidence and 95% Power)
resolution, X-fold
asymptotic limit for
LLQ-X (# of positive
wells needed)
asymptotic limit for
ULQ-X (# of negative
wells needed)
fewest total wells
for this limit
fewest total wells at
which this resolution is possible (# of positives needed
for LLQ-X, # of negatives needed for ULQ-X)
5 5 3 32 21 (6, 3)b
3 13 3 131 36 (19, 3)b
2 39 3 473 85 (55, 8)
1.5 130a 3 2110a 245 (179, 34)b
aTechnically, 129 wells is the asymptotic limit but requires >80 000 total wells, so we use 130 positive wells instead. bThe ULQ-X is X-fold higher than
LLQ-X.
Figure 5. Relationship between the total number of wells in a single-
volume system and the minimum number of positive results required to
meet the desired resolution at the LLQ-X. The symbols correspond to
the points listed in Table 3. The ULQ-X limit, not given here but
identified in Table 3, is set by the ULQ definition above of having
an average concentration corresponding to three negative wells in the
total volume.
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largest wells or specific dimensions such as depth and/or cross
section), and constraints on the overall size of the device as a
function of the number of wells used. We describe the perfor-
mance of each design in terms of parameters LDL, LLQ-X,
ULQ-X, and ULQ, which are defined and described below.
The lower detection limit, LDL, is defined as the concen-
tration which would have a 95% probability of generating at
least one positive well, i.e., a 95% probability of having at least
one molecule in the total volume of all wells. The actual
concentration is then set by the total volume. Applying these
conditions to eq 1 reveals that this corresponds to an average
concentration, λ, of three molecules in the total volume. For
the design characterized in this paper, three molecules in
24.96 μL correspond to an average concentration of 120
molecules/mL. This parameter is important to consider when
absolute sensitivity is important.
The upper limit of quantification (ULQ) is defined in a similar
fashion. Specifically, it is the concentration where the probability
of all wells being positive is 5%, or in other words, there is 95%
probability that at least 1 well is negative. The ULQ is a function
of both the smallest well volume and the number of wells at that
volume. The conditions needed to set the ULQ are determined
using eq 15, where n and v should be the values for the smallest
volume.
0:05 ¼ ð1 eðv 3 λÞÞn ð15Þ
For the design tested in this paper 1 000 000 molecules/mL
was the target for the ULQ, but the device was designed to exceed
this to allow for potential increases in concentration during
sample preparation. Setting λ = 4 000 000 molecules/mL and
testing extreme cases of total number of wells (n = 20 and 1000)
reveals that the smallest volume will be in the range of 0.51.5
nL. The actual size and number of the smallest volume wells can
then be determined by preferences of fabrication. For example, if
1 nL is the smallest volume that can be easily fabricated and
utilized, then to detect λ = 4 000 000 molecules/mL, about 160
wells are needed at this volume. Setting the ULQ is a critical
factor when setting the dynamic range and the number of wells
used in the design.
The lowest concentration that the design can distinguish
statistically from a concentration X-fold higher with the desired
confidence and power limits is defined as the lower limit of
quantification for X-fold resolution (LLQ-X). Similarly the
highest concentration at which X-fold resolution can be achieved
is designated ULQ-X. Depending on the resolution level, the
ULQdefined above can also coincide with the ULQ-X. Resolving
concentrations is a critical aspect of the design for quantification.
For the LLQ-X, a minimum number of positive wells is required.
Thisminimumnumber is dependent on the total number of wells
and decreases to an asymptotic limit as the total number of wells
increases (summarized in Table 3 and Figure 5 for a single
Figure 6. Plot of LLQ-X and ULQ-X as a function of VS at constant
total well number and total volume. For each resolution level (X), the
minimum (LLQ-X) and maximum (ULQ-X) concentrations that can
achieve the desired power level (95%) are given for each design in
Table 4. No concentration could be plotted if the resolution level (X)
could not be achieved for a given VS.
Table 4. Five Designs at Constant Total Well Number and Total Volume That Demonstrate the Impact of Changing VS on
Dynamic Range
design parameters
VS 10 8 5 2 1
design 1 2 3 4 5
well # per volume 160 160 160 160 640
well volumes (nL) 140, 14, 1.4, 0.14 136, 17, 2.125, 0.2656 125, 25, 5, 1 83, 41.5, 20.75, 10.375 39
total volume (μL) 24.89 24.86 24.96 24.90 24.96
LDL (molec./mL) 121 121 120 120 120
ULQ (molec./mL) 2.840  107 1.497  107 3.976  106 3.833  105 1.375  105
dynamic range (log(ULQ/LDL) 5.4 5.1 4.5 3.5 3.1
Figure 7. Plot of LLQ-X and ULQ-X for the designs in Table S5
(Supporting Information) demonstrates impact of VS on resolution and
total number of wells at constant total well number and dynamic range.
For VS = 10, the design consists of 36 wells each at 625, 62.5, 6.25, and
0.625 nL; for VS = 8, the design consists of 58 wells each at 378.9, 47.36,
5.92, and 0.74 nL; for VS = 5, the design consists of 160 wells each at 125,
25, 5, and 1 nL; for VS = 2, the design consists of 1100 wells each at 12, 6,
3, and 1.5 nL; and for VS = 1, the design consists of 12 000 wells at 2.08
nL. For all designs, the LDL is approximately 120molecules/mL and the
ULQ is approximately 4 million molecules/mL.
8166 dx.doi.org/10.1021/ac201658s |Anal. Chem. 2011, 83, 8158–8168
Analytical Chemistry ARTICLE
volume system with requirements of 95% confidence and 95%
power criteria used in this paper). For 3-fold resolution, 13
positives are needed and 13 molecules/(500 molecules/mL) =
26 μL, thus setting an approximate bound on the total volume of
all wells.
Barring special circumstances, it is simplest for design and
analysis to have the same number of wells at each volume and to
have the volumes related by the same VS. More wells result
in better resolution, but more total space would be required.
A smaller VS results in more overlap between volumes and thus
better resolution but decreases the size of the dynamic range; a
larger VS has the opposite effect. The above methods provide
simple starting points to design systems, but several designs can
meet the desired parameters. More precise analysis is required to
ensure that the target design criteria are met and that the chosen
design is near-optimal. The performance of each potential system
can be tested via simulations to select the most suitable design.
To enable more quantitative design of MV digital PCR devices, a
series of computer programs were written. These programs are
provided in the Supporting Information, along with their de-
scriptions in the “Computer Programs” section. These programs
were used to analyze several designs to illustrate the general
trends that one should keep in mind during the design of MV
digital PCR systems (Table 4, Figures 6 and 7, and Supporting
Information, Table S5).
First, we quantified how the VS affects resolution and dynamic
range for multivolume designs with the same total number of wells
and similar total volumes (Table 4 and Figure 6, comparison of
four theoretical MV designs and an analogous single-volume
design), under these constraints, the larger the VS, the larger the
dynamic range (up to 5.4 orders of magnitude for VS = 10), and
the lower the achievable resolution. The VS = 5 we chose for the
device described in this paper provided a suitable balance of
resolution (down to 1.5-fold from 10 120 to 200 000 molecules/
mL, 1.3 order of magnitude; 3-fold resolution from 520 to
3 980 000 molecules/mL, 3.9 order of magnitude) and a dynamic
range spanning 4.5 orders of magnitude.
Second, we quantified how VS affects resolution and the
required number of wells when we constrain the dynamic range
and total volume for each design and adjust the number of wells
at each VS (see Figure 7 and Table S5 (Supporting Information),
comparison of four theoretical MV designs and a single volume
design). Under these constraints, multivolume designs required
very few wells. For example, for a design with VS = 10, only 144
total wells were required to achieve 3-fold resolution from 730 to
1 167 000 molecules/mL, while a single-volume design required
12 000 wells to achieve 3-fold resolution over a range from 495 to
3 987 000 molecules/mL. The same design with VS = 10 and with
144 wells provided 5-fold resolution from 210 to 3 980 000
molecules/mL, similar to the single-volume design with 12 000
wells (1803 990 000 molecules/mL). The advantage of reducing
VS, down to VS = 1 for the single-volume design, is in providing
higher resolution (135003 990 000molecules/mL at 1.3-fold and
down to 1.1-fold from 127 000 to 2 250 000 molecules/mL) that
cannot be provided bymultivolume designs unless they also contain
many wells. When resolution needs to bemaximized, single volume
systems with many wells have a clear advantage as evidenced by the
application of such systems for prenatal aneuploidy detection30,37,41
and detection of copy number variations and genetic mutations
related to cancer and other diseases.16,27,30,33,35,38,40 Finally, for the
device that we validated experimentally in this paper (Design 3 in
Table 4 and Supporting Information Table S5), we plotted the
range of concentrations over which different levels of resolution are
maintained (Figure 8) using MVdPCR_RunPlot.m. As expected,
5-, 3-, and 2-fold resolution was maintained over a large portion of
the dynamic range, with the limit for this device of ∼1.5-fold
resolution at 95% power with at least 95% confidence. For this
device, the number of wells and VS used leads to a significant
overlap of confidence intervals for sets of wells of different volumes,
and therefore, the combined CI is smooth over much of the
dynamic range (also CI curves of Figure 3c,d). If VS is too large
and small numbers of wells are used or if only single volumes are
used (see individual CI curves of Figure 3c,d), the combined CI
curve may follow the variation of the CIs for individual volumes,
which would be undesirable (Figure 8b).
’CONCLUSIONS
In this paper, we described an approach to improve “digital”
(single molecule) assays and validated it using digital PCR
amplification. This platform, MV digital PCR, uses wells at
multiple volumes to quantify nucleic acids at high dynamic range
and high resolution while minimizing the total number of wells.
Using different well volumes, the upper and lower limits of
quantification are effectively decoupled to achieve the desired
performance specifications. By reducing the total number of
wells, a MV system allows for simpler device design, minimizes
sample handling, reduces contamination risks, allows for multi-
plexing by allowing for multiple assays to be performed on a
Figure 8. Simulation results of plots generated from MVdPCR_RunPlot.m for (a) the design used in this paper, and (b) Design 1 from Table S5
(Supporting Information; 36 wells each at 625, 62.5, 6.25, and 0.625 nL), revealing approximate concentration ranges over which the desired resolution
levels are achieved. The curves are for the lower of the two concentrations being resolved. LLQ-X corresponds to the concentration at which the curve
rises above 0.95 (black line), and the ULQ-X corresponds to the concentration X times higher than the concentration at which the curve drops back
below 0.95.
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single chip, and reduces the use of reagent when compared to the
multiple sample dilutions required by serial dilution.
We tested predictions of the theory by creating a rotational
SlipChip designed to satisfy requirements for quantifying HIV
viral load. For this chip, we have shown experimental agreement
with mathematical theory over the entire dynamic range, accu-
rate absolute quantification, and agreement between predicted
and experimentally observed resolution. Results from different
volumes enabledmore precise and accurate results than would be
obtained from any single volume. Separately analyzing the
experimental results from different sets of well volumes provided
a direct source for internal controls, and we demonstrated that, at
least when purified DNA and this specific PCR chemistry
implemented on SlipChip were used, there were no artifacts
due to different surface-to-volume ratios or variable concentra-
tions of single molecules in wells of different volumes. This result
would have to be confirmed further when other chemistries or
more complex sample matrixes55 are used.
In cases when the distribution of concentrations in samples is
bimodal, i.e., when some samples require quantification at high
concentrations and others at low concentrations, multivolume
systems with nonuniform volumetric steps could be used.
A multiplexed multivolume system with identical dynamic range
and resolution for each sample is described in a separate
publication,55 but multiplexed systems can also be designed
where different regions of the device can probe different dynamic
ranges and/or different resolutions by varying the volumes of
individual wells and the number of wells at each volume.
By integrating isothermal amplification and reverse-tran-
scription methods, visual readout, and sample preparation
with the MV digital PCR SlipChip, this approach would be
more widely applicable to quantification of nucleic acids under
resource-limited settings. The multivolume approach simpli-
fies readout and analysis because there are fewer wells to
visualize and analyze. SlipChip devices are compatible with
other amplification chemistries beyond PCR, such as recom-
binase polymerase amplification,56 and we expect that digital
isothermal chemistries will be successfully used in multi-
volume devices, although it remains to be experimentally
confirmed. Reverse-transcription to quantify HIV and HCV
viral RNA in multivolume devices is described in a forth-
coming paper.55 The MV digital approach described here is
also applicable in other fields that depend on Poisson statistics
for interpretation, including digital immunoassays65,66 and
stochastic confinement of bacteria67,68 or other cells.
We emphasize that the presented design guidelines and soft-
ware programs are not limited to multivolume devices, and even
current single-volume digital PCR methods would benefit from
these facile in-depth design and analysis tools.26 Single-volume
devices that use dilution series are mathematically equivalent to
multivolume devices, and the approach presented here can be
applied to design and analysis of dilution series. Finally, the
theory and software developed here is not limited to SlipChip
and is also applicable to design and analysis of other digital
analysis systems,24,26,28,30,65,66 including valve-based25,27,34,41 or
droplet-based systems.29,32,36,69,70
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